Functional production and characterization of a fibrin-specific single-chain antibody fragment from Bacillus subtilis: Effects of molecular chaperones and a wall-bound protease on antibody fragment production

Applied and Environmental Microbiology

Volumn 68, Issue 7, 2002, Pages 3261-3269

  Wu, Sau Ching ^a   Yeung, Jonathan C ^a   Duan, Yanjun ^a   Ye, Ruiqiong ^a   Szarka, Steven J ^a   Habibi, Hamid R ^a   Wong, Sui Lam ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; BLOOD; IMAGING TECHNIQUES; PRODUCTION; PROTEINS;

CELLULAR FRACTIONS;

MICROBIOLOGY;

CHAPERONE; FIBRIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MH1; PROTEINASE; UNCLASSIFIED DRUG;

BACTERIUM;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL STRAIN; CONTROLLED STUDY; ENZYME INACTIVATION; GENE CONSTRUCT; NONHUMAN; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN SECRETION; STRUCTURAL GENE;

ANTIBODY SPECIFICITY; BACILLUS SUBTILIS; BACTERIAL PROTEINS; BIOTECHNOLOGY; CELL WALL; ENDOPEPTIDASES; FIBRIN; IMMUNOGLOBULIN FRAGMENTS; MOLECULAR CHAPERONES; SERINE ENDOPEPTIDASES;

BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); POSIBACTERIA;

EID: 0036307716     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.68.7.3261-3269.2002     Document Type: Article

References (56)

1. On the interaction between single chain Fv antibodies and bacterial immunoglobulin-binding proteins
2. Bacterial expression and secretion of various single-chain Fv genes encoding proteins specific for a Salmonella serotype B O-antigen
3. scFv multimers of the anti-neuraminidase antibody NC10: Length of the linker between V(H) and V(L) domains dictates precisely the transition between diabodies and triabodies
4. Variable region sequence modulates periplasmic export of a single-chain Fv antibody fragment in Escherichia coli
5. Evaluation of bottlenecks in the late stages of protein secretion in Bacillus subtilis
6. A new enzyme immunoassay for soluble fibrin in plasma, with a high discriminating power for thrombotic disorders
7. In vivo tumor targeting of a recombinant single-chain antigen-binding protein
8. Effects of genetic engineering on the pharmacokinetics of antibodies
9. Pharmacokinetics and biodistribution of genetically-engineered antibodies
10. Solution structure of an isolated antibody VL domain
11. ScFv multimers of the anti-neuraminidase antibody NC10: Shortening of the linker in single-chain Fv fragment assembled in VL to VH orientation drives the formation of dimers, trimers, tetramers and higher molecular mass multimers
12. A new quantitative D-dimer assay appropriate in emergency: Reliability of the assay for pulmonary embolism exclusion diagnosis
13. A monoclonal antibody which recognises an epitopic region unique to the intact fibrin polymeric structure
14. Calculation of protein extinction coefficients from amino acid sequence data
15. Conjugation of plasminogen activators and fibrin-specific antibodies to improve thrombolytic therapeutic agents
16. Non-repetitive single-chain Fv linkers selected by selectively infective phage (SIP) technology
17. Proline isomerization and the slow folding reactions of the alpha subunit of tryptophan synthase from Escherichia coli
18. Single-chain Fv design and production by preparative folding
19. The rate-limiting steps for the folding of an antibody scFv fragment
20. 26-10 Fab-digoxin complex: Affinity and specificity due to surface complementarity
21. Cell-associated degradation affects the yield of secreted engineered and heterologous proteins in the Bacillus subtilis expression system
22. Protein L, a bacterial immunoglobulin-binding protein and possible virulence determinant
23. A gene (prsA) of Bacillus subtilis involved in a novel, late stage of protein export
24. The PrsA lipoprotein is essential for protein secretion in Bacillus subtilis and sets a limit for high-level secretion
25. Recombinant anti-sialidase single-chain variable fragment antibody-characterization, formation of dimer and higher-molecular-mass multimers and the solution of the crystal structure of the single-chain variable fragment/ sialidase complex
26. Enhancement of secretion and extracellular stability of staphylokinase in Bacillus subtilis by wprA gene disruption
27. Prolyl isomerases catalyze antibody folding in vitro
28. Factor XIII: Structure, activation, and interactions with fibrinogen and fibrin
29. The wprA gene of Bacillus subtilis 168, expressed during exponential growth, encodes a cell-wall-associated protease
30. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes
31. Cell-free expression of two single-chain monoclonal antibodies against lysozyme: Effect of domain arrangement on the expression
32. 99mTc anti-D-dimer MoAb detects venous thrombi in man
33. Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49
34. Degree of polymer organization decreases the binding of a monoclonal antibody raised against the beta-chain amino terminus of fibrin
35. The structure and biological features of fibrinogen and fibrin
36. Protein L from Peptostreptococcus magnus binds to the kappa light chain variable domain
37. Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts
38. Accessibility of epitopes on fibrin clots and fibrinogen gels
39. Conformation of the existence of a third family among peptidyl-prolyl cis/trans isomerases. Amino acid sequence and recombinant production of parvulin
40. Antibody-enhanced thrombolysis: Targeting of tissue plasminogen activator in vivo
41. Primary structure and functional expression of heavy- and light-chain variable region genes of a monoclonal antibody specific for human fibrin
42. The influence of protein folding on late stages of the secretion of alpha-amylases from Bacillus subtilis
43. Influence of a cell-wall-associated protease on production of alpha-amylase by Bacillus subtilis
44. Effect of the order of antibody variable regions on the expression of the single-chain HyHEL10 Fv fragment in E. coli and the thermodynamic analysis of its antigen-binding properties
45. Quantitation of the capacity of the secretion apparatus and requirement for PrsA in growth and secretion of alpha-amylase in Bacillus subtilis
46. An antifibrin monoclonal antibody useful in immunoscintigraphic detection of thrombi
47. Mapping of the immunoglobulin light chain-binding site of protein L
48. Production and purification of antibody using Bacillus subtilis as an expression host
49. Development of improved pUB110-based vectors for expression and secretion studies in Bacillus subtilis
50. Enhanced secretory production of a single-chain antibody fragment from Bacillus subtilis by coproduction of molecular chaperones
51. Engineering a Bacillus subtilis expression-secretion system with a strain deficient in six extracellular proteases
52. Efficient production of a functional single-chain antidigoxin antibody via an engineered Bacillus subtilis expression-secretion system
53. Variable immunoreactivity of D-dimer preparations for monoclonal antibody DD-3B6/22
54. Construction of protease deficient Bacillus subtilis strains for expression studies: Inactivation of seven extracellular proteases and the intracellular LonA protease
55. Isolation and characterization of Bacillus subtilis groE regulatory mutants: Evidence for orf39 in the dnaK operon as a repressor gene in regulating the expression of both groE and dnaK